-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.USD↓
Dir gefallen die Informationen zu Mind Medicine (MindMed) Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Mind Medicine (MindMed) Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Mind Medicine (MindMed) Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Mind Medicine (MindMed) Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
25 News & Informationen zur Mind Medicine (MindMed) Inc. Aktie
Mind Medicine MindMed : MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes (Form 6-K)
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
NEW YORK, September 2, 2021 — MindMed , a… | September 2, 2021
Mind Medicine MindMed : MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
NEW YORK, Sept. 2, 2021 /PRNewswire/ — MindMed , a leading biotech company developing psychedelic-inspired therapies, and BioXcel Therapeutics, Inc. , a leading clinical-stage… | September 2, 2021
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes
/PRNewswire/ — MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) (the “Company”), a leading biotech company developing psychedelic-inspired therapies, and BioXcel…
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
A lot has changed since Benzinga last spoke with Kevin O’Leary, businessman, author,
Forian : MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
NEW YORK, Aug. 24, 2021 /PRNewswire/ — Mind Medicine Inc. , , a leading biotech company developing psychedelic-inspired therapies, has agreed to work with Forian Inc. , a leading provider of… | August 24, 2021
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
NEW YORK, Aug. 24, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the 'Company'), a leading biotech com…
Mind Medicine MindMed : MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium (Form 6-K)
MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium
Mind Medicine Inc. , , a leading biotech company developing psychedelic-inspired therapies, has… | August 17, 2021
Mind Medicine MindMed : MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium
Mind Medicine Inc. , , a leading biotech company developing psychedelic-inspired therapies, has joined the Critical Path Institute's Patient-Reported Outcome Consortium to assist in the… | August 17, 2021
Mind Medicine (MindMed) Inc. (MNMD) CEO Robert Barrow on Q2 2021 Results – Earnings Call Transcript
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Q2 2021 Results Conference Call August 16, 2021 4:00 PM ET Company Participants Robert Barrow – Chief Executive Officer Dave Guebert – Chief…
MindMed Announces 2021 Q2 Financial Results; Cash Balance Of $157 USD Million ($195 CAD Million) To Execute On Diverse Clinical Pipeline
NEW YORK, Aug. 12, 2021 /PRNewswire/ — MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies,
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline
/PRNewswire/ — MindMed (Nasdaq: MNMD), (NEO: MMED), (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its…
MindMed Stock Forecast: Look for 545% Growth
Our MindMed stock forecast for 2025 looks something like market predictions ahead of the cannabis boom. Here's where MindMed stock will rise soon…
MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board
/PRNewswire/ — MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, announces the addition of…
MindMed Leverages Ayahuasca's Ingredient DMT In Psychedelic-Inspired Therapies, Launches Trials With 30 Subjects
Psychoactive brew ayahuasca is known for having a fast-onset antidepressant effect.
With serotonergic psychedelics, such…
Mydecine Innovations Group, Inc.
196k members in the CanadianInvestor community. Canadians interested in investing and looking at opportunities in the market besides being a potato …
Top Psychedelics Stocks
The psychedelics sector is growing. Here's a look at the top psychedelics stocks so far in 2021 based on year-to-date share price gains.
MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company
/PRNewswire/ — MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, and Datavant, Inc….
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the tr…
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
Institutional analysts are taking a liking to the industry …
Why This MindMed Analyst Is Bullish: 'One Of The Most Diverse Pipelines In Psychedelics'
Mind Medicine (MindMed) Inc (NASDAQ:MNMD) shares traded higher by 3.3% on Monday after one analyst initiated bullish coverage of the psychedelics …
MindMed Included in FTSE Russell 3000® Index
NEW YORK, June 28, 2021 /PRNewswire/ — MindMed , a leading psychedelic-inspired medicine company announced that effective Friday, June 25th, 2021, MindMed has been added to the FTSE Russell…
MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board
/PRNewswire/ — MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ) (the “Company”), a leading biotech company developing psychedelic-inspired therapies, has…
COMP SERVICES (CMPS), Mind Cure Health (MCURF), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC. (MYCOF) – Psyched: Compass Launches C
Compass Launches Center Of Excellence
Compass Pathways (NASDAQ:CMPS) o…
Psychedelics Stocks to Watch
As the psychedelics industry continues to grow, the Investing News Network offers a growing list of publicly traded psychedelics stocks.
Mind Medicine MindMed : MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers
MindMed to Commence Groundbreaking LSD Microdosing Study Evaluating Benefits on Neuroplasticity, Sleep, Cognitive Enhancement Variables and Immune System Response on the Human Body
NEW YORK, Jan…. | January 12, 2021